| Name | Zharp2-1 |
|---|
| Description | Zharp2-1 is an oral effective RIPK2 inhibitor, highly associated with inflammatory bowel disease (IBD). Zharp2-1 blocker muramyl dipeptide (MDP) induces growth of mononuclear cells and induces inflammatory cell factor infection. Zharp2-1 attenuates MDP-induced small inguinal peritonitis, or ameliorates by DNBS-induced large inguinal conjunctivitis[1]. |
|---|---|
| Related Catalog | |
| Target |
RIPK2[1] |
| References |
| Molecular Formula | C19H18N3O2PS |
|---|---|
| Molecular Weight | 383.40 |